Cargando…
Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug release
Tumour-associated macrophages (TAMs) support tumour development and have emerged as important regulators of therapeutic response to cytostatic agents. To target TAMs, we have developed a novel drug delivery approach which induces drug release as it inhibits cysteine cathepsin activity. This inhibito...
Autores principales: | van Dalen, Floris J., Verdoes, Martijn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487864/ https://www.ncbi.nlm.nih.gov/pubmed/36120947 http://dx.doi.org/10.1080/14756366.2022.2122961 |
Ejemplares similares
-
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer
por: Edgington-Mitchell, Laura E., et al.
Publicado: (2015) -
Controlling
Antigen Fate in Therapeutic Cancer Vaccines
by Targeting Dendritic Cell Receptors
por: Wijfjes, Zacharias, et al.
Publicado: (2023) -
Application of a Highly Selective Cathepsin S Two-step Activity-Based Probe in Multicolor Bio-Orthogonal Correlative Light-Electron Microscopy
por: van Dalen, Floris J., et al.
Publicado: (2021) -
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
por: ZHONG, YAN-JUN, et al.
Publicado: (2012) -
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
por: Wu, Yixing, et al.
Publicado: (2023)